X-135985510-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000370695.8(SLC9A6):​c.8G>T​(p.Arg3Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000363 in 1,101,352 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000030 ( 0 hom. 0 hem. )

Consequence

SLC9A6
ENST00000370695.8 missense

Scores

3
1
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.608

Publications

0 publications found
Variant links:
Genes affected
SLC9A6 (HGNC:11079): (solute carrier family 9 member A6) This gene encodes a sodium-hydrogen exchanger that is amember of the solute carrier family 9. The encoded protein localizes to early and recycling endosomes and may be involved in regulating endosomal pH and volume. Defects in this gene are associated with X-linked syndromic cognitive disability, Christianson type. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
SLC9A6 Gene-Disease associations (from GenCC):
  • Christianson syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13352051).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC9A6NM_001379110.1 linkc.-57+33G>T intron_variant Intron 1 of 17 ENST00000630721.3 NP_001366039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC9A6ENST00000370695.8 linkc.8G>T p.Arg3Leu missense_variant Exon 1 of 16 1 ENSP00000359729.4 Q92581-2
SLC9A6ENST00000370698.7 linkc.8G>T p.Arg3Leu missense_variant Exon 1 of 16 1 ENSP00000359732.3 Q92581-1
SLC9A6ENST00000630721.3 linkc.-57+33G>T intron_variant Intron 1 of 17 4 NM_001379110.1 ENSP00000487486.2 A0A0D9SGH0
SLC9A6ENST00000370701.6 linkc.-57+33G>T intron_variant Intron 1 of 16 1 ENSP00000359735.1 Q92581-3

Frequencies

GnomAD3 genomes
AF:
0.00000900
AC:
1
AN:
111127
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000190
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000303
AC:
3
AN:
990225
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
310277
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22515
American (AMR)
AF:
0.00
AC:
0
AN:
20657
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14862
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25848
South Asian (SAS)
AF:
0.00
AC:
0
AN:
41911
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25686
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2747
European-Non Finnish (NFE)
AF:
0.00000378
AC:
3
AN:
794122
Other (OTH)
AF:
0.00
AC:
0
AN:
41877
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000900
AC:
1
AN:
111127
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33391
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
30617
American (AMR)
AF:
0.00
AC:
0
AN:
10624
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3477
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2665
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5975
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.0000190
AC:
1
AN:
52734
Other (OTH)
AF:
0.00
AC:
0
AN:
1485
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Christianson syndrome Uncertain:1
Jan 07, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SLC9A6-related disease. While this variant is not present in population databases, the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change replaces arginine with leucine at codon 3 of the SLC9A6 protein (p.Arg3Leu). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and leucine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Benign
0.12
.;T
FATHMM_MKL
Benign
0.099
N
LIST_S2
Benign
0.69
T;T
M_CAP
Pathogenic
0.80
D
MetaRNN
Benign
0.13
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;L
PhyloP100
0.61
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-0.49
N;N
REVEL
Benign
0.053
Sift
Benign
0.17
T;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0
B;B
Vest4
0.20
MutPred
0.30
Loss of solvent accessibility (P = 0.1144);Loss of solvent accessibility (P = 0.1144);
MVP
0.068
MPC
1.3
ClinPred
0.27
T
GERP RS
1.6
PromoterAI
0.025
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.058
gMVP
0.63
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1016216648; hg19: chrX-135067669; API